Bridging Community Gaps Photovoice (BCGP)

September 12, 2020 updated by: Erna Sally Rogers, Boston University Charles River Campus

Randomized Trial of a Peer-led Intervention to Promote Community Living and Participation - The Bridging Community Gaps Photovoice

The purpose of this study is to test a peer-led intervention intended to promote the community living and participation of individuals with psychiatric disabilities entitled "Bridging Community Gaps Photovoice" (BCGP). The intervention targets increasing community involvement of individuals with psychiatric disabilities through reduction in self-stigma and perceived stigma, enhancing opportunities for community participation, and support to achieve community participation goals.

Study Overview

Detailed Description

The BCGP intervention is 6 months long and the investigators expect that participants will experience lower self and perceived stigma, increased community participation and sense of belonging, and improved psychosocial functioning and personal growth after the intervention. The intervention is comprised of a 12-week class that meets once a week for two hours, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The purpose of the individual support is to reinforce the class activities and to ensure the participants meets their community participation goal. The proposed study is a randomized trial which will be conducted at Boston University Center for Psychiatric Rehabilitation (BUCPR) in Massachusetts, the Mental Health Center of Denver (MHCD) in Colorado, and the Greater Bridgeport Mental Health Center (GBMHC) in Connecticut.

Study Type

Interventional

Enrollment (Actual)

197

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Denver, Colorado, United States, 80204
        • Mental Health Center of Denver
    • Connecticut
      • Bridgeport, Connecticut, United States, 06610
        • Greater Bridgeport Mental Health Center
    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Boston University, Center for Psychiatric Rehabilitation
      • Wakefield, Massachusetts, United States, 01880
        • Horizon House- Riverside Community Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. are 18 or older.
  2. are recipients of services at research sites due to having a DSM-V diagnosis of mental illness, including dual diagnosis (dual diagnosis refers to co-occurring mental illness and alcohol/ substance use disorder).
  3. are interested in enhancing their community participation.
  4. are not currently receiving individual peer support services.
  5. are able to read and write in English.

Exclusion Criteria:

1)Inability to give full and knowing consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bridging Community Gaps Photovoice (BCGP)
The BCGP program is a 6-month photovoice-based intervention to help individuals with psychiatric disabilities enhance their community participation.
Participants assigned to this group will be part of the 6-month long BCGP intervention, which involves a 12- week class that meets weekly, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The BCGP classes follow a manualized curriculum with sessions that combine didactic information, Photovoice exercises, and group discussions to empower participants in pursuing community participation goals, all refined with input from individuals with a lived experience.
No Intervention: Services as Usual
Individuals in this group continue with their regular mental health services with no additional intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
UCLA Loneliness Scale
Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months
is a 20-item 4-point Likert-type scale, widely used measure of loneliness and social isolation. Cronbach's alpha coefficients ranging from .89 to .94.
Change from Baseline to 3 months to 6 months to 9 months to 12 months
Multi-Dimensional Assessment of Community Participation
Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months
Consists of a set of objective and subjective measures of community belonging, inclusion and participation.
Change from Baseline to 3 months to 6 months to 9 months to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Internalized Stigma of Mental Illness Scale
Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months
29-item, 4-point scale from (strongly disagree to strongly agree) assesses behaviors, thoughts and feelings that are self-stigmatizing including alienation, stereotype endorsement, social withdrawal, stigma resistance.
Change from Baseline to 3 months to 6 months to 9 months to 12 months
The Stigma Scale
Time Frame: Change from Baseline to 3 months, 3 months to 6 months, 6 months to 9 months, 9 months to 12 months
28 item, 5 point scale (strongly disagree to strongly agree) measuring experienced and anticipated stigma.
Change from Baseline to 3 months, 3 months to 6 months, 6 months to 9 months, 9 months to 12 months
Approaches to Coping with Anti-Stigma
Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months
27-item instrument with a 4 point scale (strongly disagree to strongly agree) measuring strategies to cope with stigma: secrecy, withdrawal, educating, challenging, and distancing.
Change from Baseline to 3 months to 6 months to 9 months to 12 months
Personal Growth and Recovery Scale
Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months
25-item, 4 point scale (strongly disagree to strongly agree) of items measuring psychosocial functioning and recovery.
Change from Baseline to 3 months to 6 months to 9 months to 12 months
Community Goal Achievement Scale
Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months
adapted from Goal Attainment Scale, provides a structured approach to determining goal achievement regardless of the type or uniqueness of goal .
Change from Baseline to 3 months to 6 months to 9 months to 12 months
Behavior and Symptom Identification Scale (BASIS - R)
Time Frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months
A 24-item scale that measures: mood disturbances, anxiety, interpersonal and role functioning, daily living skills, psychotic symptoms, impulsivity and substance use
Change from Baseline to 3 months to 6 months to 9 months to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2017

Primary Completion (Actual)

September 11, 2020

Study Completion (Actual)

September 11, 2020

Study Registration Dates

First Submitted

September 19, 2017

First Submitted That Met QC Criteria

September 21, 2017

First Posted (Actual)

September 25, 2017

Study Record Updates

Last Update Posted (Actual)

September 16, 2020

Last Update Submitted That Met QC Criteria

September 12, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4591

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Illness

Subscribe